India, Oct. 6 -- Cohance Lifesciences announced that Crisil ESG Ratings has voluntarily assigned an ESG Rating of "Crisil ESG 61 (Strong)" and Core ESG Rating of "Crisil Core ESG 67 (Strong)" to the Company.
Published by HT Digital Content Services with permission from Pivotal Sources....